Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of ZS801 in adult Hemophilia B patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• ZS801

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Hemophilia B | Phase 1, Phase 2 | Status: RECRUITING